Dentaforce Dt Tablet 10

Dentaforce-DT Tablet can interact with medications, including:

• ACE inhibitors/Angiotensin II receptor antagonists. The concomitant use of ACE inhibitors and/or angiotensin II receptor antagonists with this tablet may increase the risk of kidney impairment.
• Antiepileptic medications such as phenytoin and carbamazepine. The concomitant use of this tablet and antiepileptic medications may increase the risk of seizures.
• Anticoagulants such as warfarin. The co-administration may cause an enhanced anticoagulant effect. 
• Other NSAIDs, such as aspirin. The concomitant use may increase the risk of adverse effects.
• Diuretics such as furosemide. The concomitant use of this tablet with diuretics can lead to a reduced diuretic effect.
• Antigout medications such as probenecid. The concomitant use may increase the concentration of this tablet in blood.
• Chemotherapy agents such as methotrexate. The concomitant use may enhance the toxicity of methotrexate.
• Psychoactive medications such as fluoxetine, thiothixene, and alprazolam. Hallucinations have been reported when this tablet was used in patients taking psychoactive medications.
• Vasoactive agents such as pentoxifylline. When this tablet is taken concurrently with pentoxifylline, there is an increased risk of bleeding.
• Selective serotonin reuptake inhibitors (SSRIs) such as citalopram. There is an increased risk of gastrointestinal bleeding when selective serotonin reuptake inhibitors (SSRIs) are combined with this tablet.

Dentaforce-DT Tablet can interact with diseases, including:

• Active or previous peptic ulcer: This tablet may also cause peptic ulcers and worsen the condition.
• History of gastrointestinal bleeding: This tablet may cause GI bleeding and worsen the condition.
• Ulceration or perforation: This tablet may exacerbate the condition.
• Severe heart failure: This tablet causes an increased risk of serious heart thrombotic events, including heart attack and stroke, which can be fatal.
• Liver impairment: This tablet may cause hepatitis & cholestatic jaundice and worsen the existing liver impairment.
• Kidney failure: This tablet is contraindicated in patients with severe kidney impairment.
• History of asthma: This tablet is contraindicated in patients with asthma due to the risk of an anaphylactic reaction (allergic reaction).
• Nasal polyps: This tablet is contraindicated in patients with nasal polyps due to the risk of anaphylactic-like reaction (allergic reaction).
• Cerebrovascular bleeding: This tablet can stop platelets from working properly, so it should not be used if someone has a suspected or confirmed bleeding problem in their brain.

The recommended dose of Dentaforce-DT Tablet should be taken as directed by your doctor. The dosage may change based on individual factors such as the severity of the condition and response to treatment. It is important to follow the prescribed dosage and not exceed it without consulting your doctor.

If you take an excessive dosage of Dentaforce-DT Tablet by accident, it is essential to take immediate medical attention from your doctor or nearby hospital. Symptoms of an overdose include lethargy, drowsiness, nausea, vomiting, and stomach pain.

If you forgot to take Dentaforce-DT Tablet, take it as soon as you remember. If the time for the next dosage is close, it is recommended to skip the missed one and resume your regular dosage pattern. Never increase your dosage without consulting your doctor.